The National Drug Authority (NDA) has been plunged into a fresh controversy after its Public Relations Manager, Abiaz Rwamwiri, was charged over alleged false accounting involving Shs296 million in public funds, in a case that raises serious questions about financial accountability within one of Uganda’s key regulatory institutions.
Rwamwiri, who has spent years defending the NDA’s operations and communicating its enforcement activities to the public, is accused of failing to properly account for a total allocation of Shs324.5 million reportedly intended to facilitate media engagements and community sensitisation programmes.
According to the charges that emerged on November 18, 2026, prosecutors allege that false accounts were submitted concerning Shs296 million of the money. This leaves Shs28.5 million outside the amount specifically cited in the false accounting charge.
But the financial allegations are not the only problem facing the NDA communications chief. He is also accused of interfering with an investigation conducted by the Inspectorate of Government (IG), reportedly by attempting to influence witnesses into giving investigators false information.
The obstruction allegations could further complicate his legal troubles, particularly because the IG is mandated to investigate corruption, abuse of office and the misuse of public resources across government institutions.
The case presents an uncomfortable development for an official who has regularly appeared before journalists condemning illegal pharmaceutical operations, counterfeit medicines and the sale of government drugs through unauthorised channels.
In August 2026, Rwamwiri briefed the media following an enforcement operation that resulted in the arrest of three suspects accused of involvement in the illegal sale of government veterinary vaccines and counterfeit products. He has also publicised operations targeting unlicensed drug outlets, particularly in northern Uganda.
Now, the NDA’s own communications manager finds himself facing allegations that place public financial accountability under the spotlight.
The controversy has triggered debate among Ugandans, with some social media users questioning the apparent contradiction between his public role in defending regulatory enforcement and the allegations now confronting him. Others have called for a thorough investigation into how money allocated for public awareness activities was handled.
The Shs324.5 million allocation was reportedly intended to support communication campaigns and community engagement aimed at educating Ugandans about counterfeit medicines, unsafe pharmaceutical products and the dangers of purchasing drugs from unlicensed outlets.
Any alleged misuse of such resources raises concerns about whether public money intended to protect consumers was properly utilised.
For the NDA, the scandal threatens to create a credibility problem at a time when public confidence in the regulation of medicines remains critical.
However, Rwamwiri remains presumed innocent until proven guilty in court. The prosecution will be required to establish its case, while the accused will have an opportunity to challenge the allegations.
As proceedings unfold, attention will turn to the evidence behind the Shs296 million accounting allegations, the circumstances surrounding the alleged witness interference and whether additional accountability questions will emerge within the authority.
Related posts:
- EXCLUSIVE! How Chinese Firm ‘Grace Textile’ Secured UGX 17Bn Tax Relief in Secretive Finance Ministry Deal As Ugandan Manufacturers Drown in Levies
- Top Story! AUSSOM Pleads for 8,000 More Troops, Air Power To Combat Al-Shabaab Resurgence
- “Any comments from the CDF are inconsequential,”- UHRC Boss Refuses to Apologise to Gen Muhoozi
- Family Sues UPDF Officers Over Fatal Shooting of 23-Year-Old Son
